Center for Connected Medicine’s Post

An international team of medics, scientists and researchers have designed an AI tool that can indicate how likely a patient is to experience problems after surgery and radiotherapy. The technology, being trialled in the UK, France and the Netherlands, could help patients access more personalised care. Dr Tim Rattay, a consultant breast surgeon and associate professor at the University of Leicester, highlights the importance of this tool in managing the side-effects of breast cancer treatment. Skin changes, scarring, lymphoedema, and even heart damage from radiation treatment can be debilitating for patients, but this AI tool can help predict and manage these side-effects. Read more about this exciting development here: https://lnkd.in/dXHtdG2x #BreastCancer #AIinHealthcare #PersonalizedCare

A breakthrough blood test which could be used to detect brain tumours is being tested by UK scientists. This new test believed to be a world-first may reduce the current invasive and risky surgery used to diagnose some brain tumours. The test works by isolating cells that have broken free from the tumour and into a person’s blood. These cells can then be identified under a microscope. The test could also lead to earlier diagnosis which means a potential increase in survival rates as treatments can start as soon as possible. It is hoped if approved, that this new test could be rolled out to health services within two years. https://lnkd.in/ed29n6JZ #cancer #cancerdiagnosis #healthcare #healthcareinnovation

Future Directions In Brain Tumor Research And Treatment - K M Bopanna Heterogeneity is probably the most defining factor in addressing the complex topic of brain tumours. Malignant brain tumours are diverse in their morphology and cellular pathways while being shielded by the blood-brain barrier, which renders effective systemic therapy a Herculean task with a grim prognosis. At present, most patients receive a generalized protocol of resective surgery followed by chemotherapy and radiation. The role of a tailored approach using precision medicine to treat brain tumours is the need of the hour to improve the outcomes of this devastating disease. It is estimated that approximately 65,000 non-malignant and 25,000 malignant brain tumours are diagnosed annually in the US, and this burden is likely increasing in keeping with the overall incidence of tumours worldwide. #worldbraintumourday #braintumorday #worldbraintumourday2024 #braintumour #braintumourresearch #drbopannakm

New published paper! This peer-reviewed study highlights the potential for #AI and wide-field (WF) OCT in breast cancer surgery to enhance productivity and decision making in surgical margin assessment, decreasing reoperation rates due to residual cancer. The results suggest the investigational* deep learning model accurately identified 96.8% of pathology positive margins in WF-OCT images with high sensitivity and specificity. Read it at https://lnkd.in/dmxWFTCM. #artificialintelligence #AI #deeplearning #healthcareinnovation #breastcancer -- *CAUTION. Investigational Device. Subject to U.S. Law. Not available for sale in the United States.

More positive news for lung cancer patients. ALK+ UK’s chair and founder, Debra Montague, is enrolled in a pioneering trial into robotic lung cancer treatment led by Professor Pallav Shah at the Royal Brompton Hospital. This innovative procedure integrates diagnosis and treatment into a single session, utilising robotic technology for unparalleled precision. With a robot-guided catheter and advanced 3D lung mapping, this method efficiently and safely targets and eradicates tumours, reducing treatment times and minimising surgical risks. This breakthrough offers new hope and could transform lung cancer care, especially for patients ineligible for traditional surgery. #LungCancer #RoboticSurgery #NSCLC #ALKPositiveLungCancer

Interventional Radiology for Cancer Interventional radiology helps with cancer in a number of ways. It can directly treat the disease, prevent bleeding during surgery, and ease pain and cancer treatment side effects. Your doctor can use interventional radiology to put cancer-killing therapies like chemotherapy and radioactive medicines directly onto tumors and cancer cells. Doctors can also kill tumors or cancer cells by heating them up with radio waves or electric currents, or freezing them with ice crystals. At the same time that they are treating the tumor, they can cut off blood flow to it as a second way of damaging tumors and cancer cells.

Exploring the Frontiers of Breast Cancer Surgery: Perimeter Medical Imaging AI's groundbreaking S-Series and B-Series OCT devices are not just technological advancements; they are beacons of hope in the fight against breast cancer. Our latest article delves into how these innovations are poised to lower reoperation rates and improve patient outcomes in Canada. Plus, get an insight into Perimeter's financial trajectory and its potential in transforming breast cancer treatment. A must-read for healthcare professionals, investors, and technology enthusiasts. #HealthcareInnovation #BreastCancerAwareness #MedicalTechnology Perimeter Medical Imaging AI https://bit.ly/3tiJeUC

#MondayMedtechNews 📰❕ An international team of medics, scientists and researchers have designed an AI tool that can indicate how likely a patient is to experience problems after surgery and radiotherapy. The technology, being trialed in the UK, France and the Netherlands, could help patients access more personalised care. The AI tool was trained to predict lymphoedema up to three years after surgery and radiotherapy using data from 6,361 breast cancer patients. Patients found to be at a higher risk of arm swelling could be offered alternative treatments or additional support during and after treatments. The AI tool correctly predicted lymphoedema in an average of 81.6% of cases and correctly identified patients who would not develop it in an average of 72.9% of cases. The overall predictive accuracy of the model was 73.4%. #clincialtrial #ai #medicalai #medicaltechnology

NOW ONLINE The findings of this study offer insights into #RectalCancer treatment response, guiding personalized therapeutic strategies 🔓 OPEN ACCESS ➡ https://lnkd.in/epE9wkya The response to preoperative radiotherapy or chemoradiotherapy in rectal cancer is highly heterogeneous, with up to 30% of patients showing a complete pathological response at surgery. This large study combining clinical and sequencing data from a cohort of patients with locally advanced rectal cancer found that mutations in SMAD4 and SYNE1 were associated with higher complete response rates. However, inclusion of mutation status for specific genes only marginally improved complete response prediction models. The findings may pave the way for personalized interventions, optimizing outcomes and addressing current challenges in rectal cancer pre-operative treatment.

Empowering patients through prostate cancer recovery. Prostate cancer surgery and recovery are undoubtedly challenging, and providing comprehensive support to patients is crucial for optimal outcomes.  Pro-Recover, our digital health solution, is designed to improve patient outcomes post the prostate cancer surgery journey, particularly focusing on the period before and after robotic prostatectomy.  Developed in collaboration with Professor Prasanna Sooriakumaran MA(Oxon) MD PhD (Prof PS), a world-leading urologist and with the input from individuals with prostate cancer experience, Pro-Recover was launched in an 8-week time frame to provide patients with a user-friendly interface to navigate their post-surgery recovery.  Currently in use at select urology clinics in London, Pro-Recover reiterates the positive impact technology can have on healthcare. Find out more about how it supports individuals in their prostate cancer recovery. https://lnkd.in/eaA3B2Dv #DigitalHealth #ProstateCancer #HealthcareInnovation #PatientEmpowerment #Avegen